English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
News
Join Professor Millot discussing TFR in children with CML - April 27th at 13.00 CET
April 2021 - Please join us for our next iCMLf Conversation on CML.
Next Tuesday, on April 27th at 13.00 CET, Professor Fréderic Millot will provide an overview of the biological and clinical characteristics of pediatric CML and an update on clinical data and relevant guidelines and recommendations. His main focus during the expert talk will be on treatment-free remission in children with CML.
Update on pediatric CML: Treatment-free remission in children with CML on April 27th at 13.00 CET
- Professor Fréderic Millot, University of Poitiers (France)
How can I dial into the webinar?
Please join this meeting from your computer, tablet or smartphone: https://us02web.zoom.us/j/81787321991
Meeting-ID: 817 8732 1991
Please join us for iCMLf conversations on COVID-19 vaccines and CML in non-english languages
April 2021 - After the successful expert talk in English, we are happy to host a series of iCMLf Conversations on COVID-19 vaccines and CML in different languages over the next couple of weeks.
Please save the date for conversations in Portuguese and Russian.
World Health Day on April 7 - Building a fairer, healthier world
April 2021 - Today is World Health Day! We will continue to do our best to build a fairer, healthier world for patients with CML. During these extraordinary times and current challenges for global health related to COVID-19, our main focus is to support physicians treating patients with CML around the world and to gain and share knowledge about COVID-19 and CML.
The iCMLf is collecting details of CML patients diagnosed with COVID-19. To date we have collected a total number of 642 cases from 48 countries. The iCMLf CML and COVID-19 data was first presented at ASH 2020 and a full publication is expected soon.
We are also putting together a CML vaccination study across sites in 15 countries to assess patients' attitude to being vaccinated, the actual uptake of vaccine by patients, potential side effects/toxicities associated with the vaccines and evidence of immunity by serology. More information will be provided soon.
Join our expert talk on COVID-19 vaccines and CML on April 7th at 13.30 CET
March 2021 - The iCMLf continues to support the global CML community during the pandemic by providing the latest information on COVID-19 and CML. With the increasing availability of COVID-19 vaccines, up to date and relevant information is imperative for physicians treating blood cancers and their patients. The next highlight in our series of iCMLf Conversations is coming up with an expert talk on COVID-19 vaccines and CML to be held Wednesday, April 7th at 13.30 CET.
Don’t miss this opportunity to stay up to date with the latest developments on COVID-19 vaccines for people with CML.
iCMLf Conversation on CML:
Update on COVID-19 vaccines and CML
Date: Wednesday, April 7th at 13.30 Central European Time (CET)
23rd Annual John Goldman CML Conference: Call for abstracts
Mandelieu La Napoule - NEW DATES: October 7-10, 2021
Chairs: J. Cortes, T.P. Hughes, D.S. Krause
Presentation of data at this conference will not jeopardize acceptance of the same at the following ASH congress.
Deadline for Abstracts: May 8, 2021
Click here to submit your abstract
Contact: camille.dufour@univ-paris-diderot.fr
Equity for people living with a rare disease - February 28th is Rare Disease Day!
February 2021 - Today we join many other organizations supporting rare diseases and patients all over the world to raise awareness for rare diseases and their impact on patients lives.
There are over 300 million people living with a rare disease worldwide. Access to appropriate monitoring and treatment is still especially challenging in low- and middle-income countries.
CML is a rare condition and we will continue to improve access to treatment and care for patients affected by CML all over the world through our programs for physicians from the emerging regions and through our online education.
